Nettside: CAM Cancer
NAFKAMs engelskspråklige og evidensbaserte nettside om alternative kreftbehandlinger, myntet spesielt på helsepersonell.
Pågående forskningsprosjekter:
Path: Å forstå kreftpasienters behandlingsforløp
Studien er en helhetlig beskrivelse av valg og resultat av skolemedisinske, komplementære og alternative behandlingstiltak hos kreftpasienter.
TCM - som tilleggsbehandling til standard kreftbehandling
Akupunktur, tradisjonelle kinesiske medisinske råd og tradisjonelle kinesiske urter blir brukt som tilleggsbehandling hos pasienter med endetarm/ tykktarmskreft.
Utvikling av web-verktøy for bedring av kommunikasjon mellom helsepersonell og kreftpasienter om bruk av alternativ behandling
Et kommunikasjonsverktøy som kan redusere risiko og øke sikkerheten for pasienter som ønsker å kombinere konvensjonell og alternativ behandling i kreftomsorgen.
Avsluttede forskningsprosjekter:
SENCANCER
Å kjenne på sykdom i hverdagen: Omsorgssøking og oppfatning av symptomer blant kroniske kreftpasienter.
Fagartikler:
2020
Stub T, Kristoffersen AE, Overvåg G, Jong MC. An integrative review on the information and communication needs of parents of children with cancer regarding the use of complementary and alternative medicine. BMC Complementary Medicine and Therapies. 2020;20(1):90.
2019
Agnete E. Kristoffersen, Trine Stub, Ann Ragnhild Broderstad, Anne Helen Hansen. Use of traditional and complementary medicine among Norwegian cancer patients in the 7th Tromsø study. Submitted to BMC Complementary and Alternative medicine. 2019;19(1):341.
Salamonsen, A. Best Practice Nordic Onkologi/Hematologi 2019 s. 38-40
«Hva er viktig for deg?» Pasientperspektiver på pasientforløp og kreftomsorg blant personer som lever med endetarmskreft.
2018
Stub T, Quandt SA, Arcury TA, Sandberg JC, Kristoffersen AE. Conventional and complementary cancer treatments: Where do conventional and complementary providers seek information about these modalities? BMC Complementary and Alternative Medicine 2018;18(1):854.
Stub T, Quandt SA, Arcury TA, Sandberg JC, Kristoffersen AE. Attitudes and knowledge about direct and indirect risks among conventional and complementary health care providers in cancer care. BMC Complementary and Alternative Medicine, 2018;18(1):44.
2017
Stub T, Quandt SA, Arcury TA, Sandberg JA, Kristoffersen AE. Complementary and conventional providers in cancer care: Experience of communication with patients and steps to improve communication with other providers. BMC Complementary and Alternative Medicine, 2017 17:301 DOI 10.1186/s12906-017-1814-0.
Salamonsen, Anita; Bakken, Solveig Rostøl; Hansen, Frank; Berntsen, Gro Karine Rosvold. Sykepleien 2017
Pasientforløp og behandlingsbehov sett fra pasienters perspektiv.
2016
Stub T, Quandt SA, Arcury TA, Sandberg JC, Kristoffersen AE, Musial F , et al. BMC Complementary Altern Med. 2016;16(1):1-14.
Perception of risk and communication among conventional and complementary health care providers involving cancer patients’ use of complementary therapies: a literature review.
Anita Salamonsen; Mona A. Kiil; Agnete Kristoffersen; Trine Stub; Gro Berntsen, 2016;10:1591-1600.
My cancer is not my deepest concern": Life course disruption influencing patient pathways and healthcare needs among persons living with colorectal cancer. Patient Preference and Adherence
Jill Hervik and Trine Stub. Breast Cancer Research and Treatment (accepted for publication) DOI: 10.1007/s10549-016-4002-x (October 2016)
Adverse effects of non-hormonal pharmacological interventions in breast cancer survivors, suffering from hot flashes. A systematic review and meta-analysis.
CAM-Cancer’s position paper on terminology Written by CAM-Cancer Executive Committee and Editors and the CAM-Cancer Consortium. February 9, 2016, CAM-Cancer
2015
Stub T, Musial F, Quandt SA Arcury TA, Salamonsen A, Kristoffersen A, Berntsen G.
BMJ Open. 2015 Sep 3;5(9):e008236. doi: 10.1136/bmjopen-2015-008236. PubMed PMID: 26338839; PubMed Central PMCID: PMC4563259.
Mapping the risk perception and communication gap between different professions of healthcare providers in cancer care: a cross-sectional protocol
Fønnebø V.
[Re: A woman in her forties with cancer, syncope and spasms]. Tidsskr Nor Laegeforen. 2015 Jan 27;135(2):104. doi: 10.4045/tidsskr.14.1600. eCollection 2015 Jan 27. Norwegian. PubMed PMID: 25625971.
Salamonsen A.
Eur J Public Health. 2015 Oct 8. pii: ckv184. PubMed PMID: 26450914.
Use of complementary and alternative medicine in patients with cancer or multiple sclerosis: possible public health implications
Mulkins AL, McKenzie E, Balneaves LG, Salamonsen A , Verhoef MJ.
From the conventional to the alternative: exploring patients' pathways of cancer treatment and care J Complement Integr Med. 2015 Aug 8. PubMed PMID: 26259233.
Health professionals and cancer patients: how to communicate effectively about complementary, integrative and alternative medicine
By Anita Salamonsen, MSc, PhD and Moshe Frenkel, MD, 2015 , CAM-Cancer
2013
Salamonsen A, 2013.
NAFKAM, UiT The Arctic University of Norway.
Boundary walkers. The use of complementary and alternative medicine in a Scandinavian health care context
Kristoffersen A E, 2013.
NAFKAM, University of Tromsø
Use of complementary and alternative medicine among Norwegian cancer patients.
Kristoffersen, E A; Norheim, A J; Fønnebø V.
Evid Based Complement Alternat Med. 2013;2013:318781. doi: 10.1155/2013/318781. Epub 2013 Mar 28
Complementary and Alternative Medicine Use among Norwegian Cancer Survivors: Gender-Specific Prevalence and Associations for Use
Salamonsen, A..
Scand J Caring Sci. 2013 Mar;27(1):70-6. doi: 10.1111/j.1471-6712.2012.01002.x.
Doctor-patient communication and cancer patients' choice of alternative therapies as supplement or alternative to conventional care
Kalager, M; Løberg, M; Fønnebø, V; Bretthauer, M.
International Journal of Cancer 2013. ISSN 0020-7136.s doi: 10.1002/ijc.28244.
Failure to account for selection-bias.
2012
Kristoffersen, A E; Norheim; A J, Fønnebø, V..
BMC Complementary and Alternative Medicine 2012 ;Volum 12.(1) 10.1186/1472-6882-12-1
Any difference? Use of a CAM provider among cancer patients, coronary heart disease (CHD) patients and individuals with no cancer/CHD
Salamonsen, A.; Kruse, T; Eriksen, S H.
Qual Health Res November 2012 vol. 22 no. 11 1497-1512.Published online August 21, 2012 DOI: 10.1177/1049732312457077
Modes of Embodiment in Breast Cancer Patients Using Complementary and Alternative Medicine
Yang, G; Li, X; Li, X; Wang, L; Li, J; Song, X; Chen, J; Guo, Y; Sun, X; Wang, S; Zhang, Z; Zhou, X; Liu, J. Evidence-based Complementary and Alternative Medicine 2012 s.
Traditional Chinese Medicine in Cancer Care: A Review of Case Series Published in the Chinese Literature
2011
Liu, J; Li, X; Liu, J; Ma, L; Li, X; Fønnebø, V.
Forschende Komplementärmedizin / Research in Complementary Medicine 2011; Volum 18. s. 257-263.
Traditional Chinese Medicine in Cancer Care: A Review of Case Reports Published in Chinese Literature
Use of placebo in cancer research: By Vinjar Fønnebø, NAFKAM, University of Tromsø, Norway and Edzard Ernst, Complementary Medicine, Peninsula Medical School, Universities of Exeter & Plymouth, UK, march 2011, published at
Musial, F; Büssing, A; Heusser, P; Choi, K-E; Osterman, T.
Forschende Komplementärmedizin / Research in Complementary Medicine 2011; Volum 18.(4), doi: 10.1159/000330714.
Mindfulness-Based Stress Reduction for Integrative Cancer Care – a Summary of Evidence
2009
Chen, S; Flower, A; Ritchie, A; Molassiotis, A; Liu, J; Yu, H; Lewith, G.
Lung Cancer. 2009 Dec 16. [Epub ahead of print].
Oral Chinese herbal medicine (CHM) as an adjuvant treatment during chemotherapy for non-small cell lung cancer: A systematic review
Kristoffersen, AE; Fønnebø, V; Norheim, AJ.
Journal of Alternative and Complementary Medicine2009; Volum 15.(1) s. 35-40.
Do cancer patients with a poor prognosis use Complementary and Alternative Medicine more often than others?
2008
Kristoffersen, AE; Fønnebø, V; Norheim, AJ.
Journal of Alternative and Complementary Medicine 2008
Use of complementary and alternative medicine among cancer patients. Classification criteria determine level of use.
Liu, JP; Xing, JM; Fei, YT.
Chinese Medicine 2008; 3:12, doi:10.1186/1749-8546-3-12
Green tea (Camellia sinensis) and cancer prevention: a systematic review of randomized trials and epidemiological studies.
2007
Lejeune S, Baum M, Heine N, Fønnebø V.
Controversies around Complementary and Alternative Medicine (CAM) in cancer. Nature Clinical Practice Oncology 2007 In press.
Verhoef M, Paterson C., Fønnebø V;
Supportive Care in Cancer, 2007; Vol 15, No 8; pp 999-1002.
Cancer and complementary medicine - an international perspective
2006
Verhoef M, Vanderheyden LC, Fønnebø V.
Integr Cancer Ther 2006;5:287-92.
A whole systems research approach to cancer care: Why do we need it and how do we get started?
Lewith G, Thomas K, Fønnebø V.
(Sommarøy), 14-16 September, 2005.
Complement Ther Med 2006;14:157-64
Whole systems research in cancer care - report of meeting in Tromsø
2005
Steinsbekk, A; Launsø, L.
Empowering the cancer patient or controlling the tumor? A qualitative study of how cancer patients experience consultations with complementary and alternative medicine practitioners and phycisians, respectively.
Integrative Cancer Therapies 2005.
2003
Kimby, C; Launsø, L*; Henningsen, I; Langgaard, H.
The Journal of Alternative and Complementary Medicine, 2003 Aug;9(4):549-61.
Choice of Unconventional Treatment by patients with cancer.
1994
Brendstrup E, Launsø L.
A Description of a Holistic Treatment Model - Used by Cancer Patients and Research Evaluated. Townsend Letter for Doctors, december 1994 (pp. 1342-56) og januar, 1995 (pp.54-61), USA.
